Cargando…

Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis

BACKGROUND: Leucine-rich alpha-2-glycoprotein-1 (encoded by LRG1) has been shown to be involved in multiple cancer progression and angiogenesis. LRG1 has been shown to be one of the five plasma proteins that can be used for colorectal cancer (CRC) diagnosis. The objective of the current study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, De-Cong, Shi, Yan, Wang, Ling-Xiong, Lv, Yao, Han, Quan-Li, Wang, Zhi-Kuan, Dai, Guang-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630435/ https://www.ncbi.nlm.nih.gov/pubmed/29029535 http://dx.doi.org/10.18632/oncotarget.16289

Ejemplares similares

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma
por: Honda, Hiromi, et al.
Publicado: (2016)

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis
por: Fujimoto, Minoru, et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
por: Grzesiak, Lucile, et al.
Publicado: (2023)

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
por: Zhang, Qian, et al.
Publicado: (2018)

Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma
por: Yan, Weiwei, et al.
Publicado: (2018)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2022)

Independent prognostic importance of microvessel density in endometrial carcinoma.
por: Salvesen, H. B., et al.
Publicado: (1998)

Independent prognostic importance of microvessel density in endometrial carcinoma
Publicado: (1998)

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Disease Activity Biomarker in Patients with Rheumatoid Arthritis
por: Ha, You Jung, et al.
Publicado: (2014)

Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 Cells
por: Xiao, Shishan, et al.
Publicado: (2018)

Gene expression of leucine-rich alpha-2 glycoprotein in the polypoid lesion of inflammatory colorectal polyps in miniature dachshunds
por: OHTA, Hiroshi, et al.
Publicado: (2020)

ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand
por: Weivoda, Starchild, et al.
Publicado: (2008)

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
por: Yoshimura, Tetsuhiro, et al.
Publicado: (2021)

Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
por: Otsuru, Toru, et al.
Publicado: (2019)

Serum and Urine Biomarker Leucine-Rich Alpha-2 Glycoprotein 1 Differentiates Pediatric Acute Complicated and Uncomplicated Appendicitis
por: Kakar, Mohit, et al.
Publicado: (2021)

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients
por: Popova, Anna, et al.
Publicado: (2022)

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023)

Monitoring of leucine‐rich alpha‐2‐glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients
por: Ito, Takahiro, et al.
Publicado: (2023)

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker
por: Shinozaki, Eiji, et al.
Publicado: (2018)

Upregulation of leucine-rich alpha-2 glycoprotein: A key regulator of inflammation and joint fibrosis in patients with severe knee osteoarthritis
por: Sarkar, Ashish, et al.
Publicado: (2022)

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn’s Disease
por: Saiki, Takuto, et al.
Publicado: (2023)

Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
por: Kono, Masashi, et al.
Publicado: (2023)

Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis
por: Arredondo Montero, Javier, et al.
Publicado: (2023)

Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus
por: Nakajima, Madoka, et al.
Publicado: (2011)

Transforming Endothelium with Platelet‐Rich Plasma in Engineered Microvessels
por: Nagao, Ryan J., et al.
Publicado: (2019)

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
por: Shinzaki, Shinichiro, et al.
Publicado: (2021)

Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis
por: Nakamura, Naohiro, et al.
Publicado: (2023)

Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission
por: Nasuno, Masanao, et al.
Publicado: (2023)

Correction to: Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis
por: Montero, Javier Arredondo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jve1jcobd51bj635t0irn30rdp